| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
153,922,000 |
| Market
Cap: |
6.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$36.9 - $39.95 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
40,000 |
561,286 |
| Total Sell Value |
$0 |
$0 |
$1,546,400 |
$15,378,126 |
| Total People Sold |
0 |
0 |
1 |
5 |
| Total Sell Transactions |
0 |
0 |
2 |
30 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Simms Christopher Paul |
Senior Vice President, CCOOffi |
• – – |
2021-08-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,000 |
|
69% |
|
| Blumenkranz Mark S. |
Director |
– • – |
2021-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2021-01-04 |
4 |
S |
$6.85 |
$81,344 |
D/D |
(11,875) |
86,466 |
|
6% |
|
| Carroll David Francis |
SVP, CFO and Treasurer |
• – – |
2021-01-04 |
4 |
S |
$6.85 |
$81,344 |
D/D |
(11,875) |
80,165 |
|
6% |
|
| Westby Keith |
SVP & COO |
• – – |
2020-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,500 |
98,341 |
|
- |
|
| Carroll David Francis |
SVP, CFO and Treasurer |
• – – |
2020-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,500 |
92,040 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2020-12-14 |
4 |
S |
$7.16 |
$32,413 |
D/D |
(4,527) |
65,841 |
|
5% |
|
| Guyer David R |
Executive Chairman |
• • – |
2020-12-14 |
4 |
S |
$7.16 |
$66,373 |
D/D |
(9,270) |
70,113 |
|
5% |
|
| Westby Keith |
SVP & COO |
• – – |
2020-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
70,368 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2020-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,200 |
79,383 |
|
- |
|
| Carroll David Francis |
SVP, CFO and Treasurer |
• – – |
2020-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
59,540 |
|
- |
|
| Sblendorio Glenn |
President and CEO |
• • – |
2020-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,950 |
273,773 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2020-12-10 |
4 |
S |
$6.96 |
$25,585 |
D/D |
(3,676) |
57,868 |
|
13% |
|
| Guyer David R |
Executive Chairman |
• • – |
2020-12-10 |
4 |
S |
$6.96 |
$66,830 |
D/D |
(9,602) |
62,183 |
|
13% |
|
| Westby Keith |
SVP & COO |
• – – |
2020-12-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
61,544 |
|
- |
|
| Sblendorio Glenn |
President and CEO |
• • – |
2020-12-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,750 |
250,823 |
|
- |
|
| Carroll David Francis |
SVP, CFO and Treasurer |
• – – |
2020-12-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
47,040 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2020-12-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,813 |
71,785 |
|
- |
|
93 Records found
|
|
Page 4 of 4 |
|
|
